10,14USD

1,53USD

17,77%

15:30:10

BTT

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt für 0 Euro bei ZERO ordern (zzgl. Spreads)

ISIN: KYG2851K1206

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
21:07:52	10,250	2

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt

Weitere Meldungen

20:44		Meet the Dividend King Stock That Yields More Than Quadruple the S&P 500. Here's Why It's a Buy in August.
20:43		Better Buy: Palantir at 108 Times Forward Earnings or Tesla at 190 Times?
20:33		The national debt is about to hit $40 trillion. Here’s how it can hurt Americans.
20:30		Warren Buffett's 12-Word Strategy for Navigating a Fear-Driven Market
20:16		US chip stocks slide as government borrowing costs hit multiyear highs
20:15		Why CoreWeave Stock Is Down 11.8%
20:15		Nike Just Hit a 12-Year Low. Is the Bottom Near?
20:07		What's Going On With Western Digital Stock Tuesday?
20:02		Barbie box office smash isn’t yet a boon for Mattel
20:02		2 Vanguard Funds to Buy and Hold for Long-Term Safety and Dividends
20:00		Top 10: Der beste In-Ear-Kopfhörer im Test - AKG & Technics vor Apple & Sony
19:57		1 Quantum Stock Near 52-Week Lows With Nvidia Partnership Backing Is Poised to Rebound
19:56		Caterpillar Costs the Dow 255 Points and Most Stocks Barely Notice
19:53		Why Intel Stock Is Falling Today
19:51		IREN Is Quietly Outpacing CoreWeave on One AI Metric that Matters
19:48		Is the Bottom in for Netflix Stock?
19:42		Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
19:37		BioMarin Seeks to Strengthen Market Position in Rare Bone Disease Treatment
19:35		Bloom Energy Stock Is Tumbling Tuesday: What's Happening?
19:28		Why Meta Platforms Stock Crashed Today
19:25		Elon Musk Says SpaceX Will Hit $1 Trillion in Revenue by 2030 -- 1 Year Faster Than the Original Timeline. Here's the Math Behind the New Number.
19:21		Prediction: SpaceX Stock Will Be Worth This Much in 1 Year
19:15		Is Nebius a Buy After Last Week's Earnings? Here's My Honest Take
19:15		Broadcom's Stock Has Beaten the Market in 12 of the Past 13 Years, and It Could Do It Again in 2026
19:14		Can Burnham save Britain’s high streets?
19:13		Amazon Raises Louisiana Investment To $18 Billion, Adds Third Data Center Campus
19:12		Haemonetics Shares Hit New 52-Week High: What's Happening?
19:08		Realty Income Yields 5.2%. Here's Why the Payout Keeps Growing.
19:03		Wheaton’s new CEO sees billion-dollar streaming era
19:02		Here’s the case for Nvidia’s stock to climb 55%, according to BofA
19:01		Captura, ElectraLith team up on next-gen lithium technology
19:01		Nvidia vs. Micron: One Sells AI Chips, One Sells the Memory Next to Them. Here's Which Stock Actually Benefits More From the 2026 AI Infrastructure Buildout.
19:00		What Does the Sale of Atlassian Stock Worth $1.2 Million by Its Chief Revenue Officer Mean for Investors?
18:59		Ondas Adds Israeli Defense Manufacturing Muscle In $33 Million Deal
18:58		Elon Musk and Jensen Huang Are Reshaping AI's Future
18:56		Stock of the Day: Sandisk Is Down 8%, but the Breakout May Still Be Intact
18:54		Soon you can buy Medicare Advantage plans at Costco. What you need to know.
18:46		Why Klarna Stock Crashed 22% on Tuesday Morning
18:45		Here's How Much $1000 Invested In Lowe's Companies 15 Years Ago Would Be Worth Today
18:43		Nvidia Stock Has 55% Upside, Analyst Says — Here’s What Investors Miss
18:43		Full Transcript: Corporacion America Q2 2026 Earnings Call
18:40		Nasdaq Drops, Chip Stocks Crater As Bond Yields Bite: Stock Market Today
18:39		Weave Is Going Private: Francisco Partners Offers 34% Premium in $650 Million Buyout
18:37		Which International ETF Is the Better Buy: Schwab's Developed Markets SCHF or iShares' Emerging Markets IEMG?
18:31		How Much Do You Need To Retire? Your Spending and Withdrawal Rate Can Change the Answer
18:30		Here's How Much $100 Invested In Goldman Sachs Group 10 Years Ago Would Be Worth Today
18:30		Meet the Super Semiconductor Stock Crushing Nvidia in 2026
18:29		Nokia Plans Near-Total China Exit As Domestic Rivals Gain Ground: Report
18:28		What's Going On With Cerebras Systems Stock Tuesday?
18:23		1 Unstoppable Stock to Buy Before It Joins Microsoft in the $3 Trillion Club

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Javelin Minerals Spring Valley Acquisition a Luxury Real Estate Investment Fund Orangekloud Technolog a Dhillon Freight Carrier

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	18.08.2026 21:24
Kaufwert:	EUR
	Hinzufügen Speichern

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt Aktie

ISIN: KYG2851K1206

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt Times and Sales (NAS)

Analysen zu Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt

Weitere Meldungen